ISRCTN15977623进行中（未招募）未知
Intermediate type 2 diabetes trial
Bioepic Ltd0 个研究点目标入组 72 人开始时间: 2022年6月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Type 2 diabetes
排除标准
- •1. Body mass index < 18.5 kg/m2
- •2. Pregnancy or lactating
- •3. Participation in any clinical study during the previous 2 months
- •4. Any other condition that in the opinion of the investigator would interfere with the evaluation of the study results or constitute a health risk for the participant
- •5. Any medication that in the opinion of the investigator would interfere with the evaluation of the study results
- •6. Recreational or illicit drug intake
- •7. Individuals who fail to utilise the Smartphone App appropriately
- •8. Aversion to the sight of blood
- •9. Severe coronary heart disease
- •10. Participants with known uncontrolled hypertension (i.e. >160mmHg systolic or >95 mmHg diastolic)
- •11. Severe renal impairment (eGFR<15ml/min)
研究者
相似试验
已完成
不适用
Early Diabetes Intervention TrialImpaired glucose toleranceNutritional, Metabolic, EndocrineDiabetesISRCTN96631607Bayer plc and Merck-Lipha (UK)631
招募中
不适用
Phase II, randomized, double-blind clinical trial for efficacy of Granulocyte-colony stimulating factor(G-CSF) and autologous cord blood infusion in children with cerebral palsyKCT0002512Hanyang University Seoul Hospital98
已完成
不适用
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitusJPRN-UMIN000011287General incorporated Tokyo Physicians Association.100
尚未招募
2 期
Pilot Clinical Trial for Treatment of Diabetic Foot Ulcers with Dietary Nano-formulated Phytochemicalsdiabetic foot ulcersMetabolic and Endocrine - DiabetesACTRN12610000565044CamMedica, Ltd.35
已完成
4 期
DIAbetes-PREvention Trialpre-diabeticiHeart problemspre-diabetics10011082NL-OMON38088Isala Klinieken78